Google+ Google+

Actos Recall is Overdue: Reasons It’s Time For An Actos Recall in the U.S


The diabetes drug Actos was recalled in France and Germany in June 2011 because studies showed it increased patients’ risks of developing bladder cancer and congestive heart failure. But instead of requesting an Actos recall n the U.S., the FDA merely issued a warning about the risk of bladder cancer.

In the time since France and Germany recalled Actos, there have been two new studies confirming the bladder cancer risk (June 1, 2012 and July 3, 2012). There has also been a study (June 11, 2012) showing that Actos increases the risk of macular edema, which causes blurred vision.

Actos bladder cancer victims have filed so many lawsuits that the federal lawsuits have been consolidated in Actos Multidistrict litigation. Both California and Illinois have a number of consolidated Actos lawsuits filed in their state courts.

According to an Associated Press article, Takeda Pharmaceutical Co., Ltd. (“Takeda”), the maker of Actos, took in $3.4 billion in sales of Actos in the U.S. in 2011. Pardon me if I wonder if the maker of Acts cares more about profits that it does the health of people with diabetes.

Money in medicine bottles.To try to build public support for an Actos recall, I’ve created a Recall Actos Facebook Page, a Recall Actos Google+ Page, a RecallActos Twitter account, and a website where people can sign a petition calling for a recall.

I’ve also created a website where Actos patients who developed bladder cancer (and their family members) can get information and obtain a free legal evaluation of their potential Actos lawsuit.

The Actos lawsuit website includes shocking excerpts from an Actos whistleblower lawsuit filed by a former medical researcher for Takeda. The website also offers people with bladder cancer (and their family members) the opportunity to obtain a free Actos lawsuit review by calling 800-671-0996 toll free, 24 hours a day, 7 days a week or using the website’s Free Actos Lawsuit Review Form.


If you take Actos, you should continue taking it until you can schedule an appointment to discuss the drug’s risks with your doctor. And between now and your appointment, do some research on the risks of the drug. A good place to begin your research is the Actos Lawsuit Background post at That post gives a good history of the regulatory background and the studies regarding Actos and bladder cancer.

Actos® is one of the trade names under which the drug pioglitazone is marketed. ACTOS, ACTOplus met, ACTOplus met XR, and Duetact are trademarks of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals U.S.A., Inc.

About Michael J. Evans

Michael J. Evans is a personal injury lawyer who represents people with claims involving defective medicine or medical devices, other defective products that cause serious injury or death, and environmental cases. Evans also handles whistleblower lawsuits in which employees, or former employees, expose fraud or other illegal conduct by the corporation for which they work(ed), Evans organizes litigation groups of plaintiffs law firms to work with him on these cases nationwide. Evans uses social media, blogs, online video, mobile apps and traditional media to connect with clients, and help other prominent law firms connect with clients.. Evans is also an advocate for the rights of consumers. His primary areas of legal practice are mass torts, and advising law firms on the ethical rules and law governing legal marketing via the Internet and social media.

Attorney Advertising

No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers. The hiring of a law firm is a serious decision that should not be based on advertising alone.